Combined modalities approach for localized adult extremity soft-tissue sarcoma

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Extremity soft-tissue sarcomasare a heterogeneous group of rare neoplasms, characterized by a broad spectrum of biological aggressiveness and a uniform tendency for local failure if not adequately treated. Surgery is the mainstay of therapy, and the availability of multidisciplinary surgical skills allows adequate margins with acceptable morbidity to be obtained. Local therapies, such as radiation therapy or isolated limb perfusion, alone or in combination with systemic agents, may help to further improve local control, especially in difficult presentations. The possible impact of systemic treatment on survival is still a matter of debate, and the agents used so far have not provided a major breakthrough, even in selected populations at high dsk of disease spread. Nevertheless, soft-tissue sarcomas are no longer considered a unique disease. More than 50 different histotypes can now be well recognized, with distinct biological and molecular characteristics, which lead to different clinical behavior and a potentially different sensitivity to targeted agents. Therefore, it is more essential than ever for treatment of these patients to be delivered in referral centers, where a dedicated multidisciplinary team is able to administer histology and clinically driven approaches. The employment of combined modalities will be able to maximize the chance of local cure even in difficult presentations, and possibly improve survival, especially in high-risk disease.

Original languageEnglish
Pages (from-to)1135-1144
Number of pages10
JournalExpert Review of Anticancer Therapy
Volume7
Issue number8
DOIs
Publication statusPublished - Aug 2007

Fingerprint

Sarcoma
Extremities
Survival
Therapeutics
Histology
Radiotherapy
Referral and Consultation
Perfusion
Morbidity
Population
Neoplasms

Keywords

  • Chemotherapy
  • Combined modalities
  • Isolated limb perfusion
  • Limb
  • Prognosis
  • Radiotherapy
  • Sarcoma
  • Surgery
  • Targeted therapy

ASJC Scopus subject areas

  • Pharmacology
  • Cancer Research

Cite this

Combined modalities approach for localized adult extremity soft-tissue sarcoma. / Gronchi, Alessandro; Olmi, Patrizia; Casali, Paolo G.

In: Expert Review of Anticancer Therapy, Vol. 7, No. 8, 08.2007, p. 1135-1144.

Research output: Contribution to journalArticle

@article{9a5b72a3331b40eba35e9bf9952d01c3,
title = "Combined modalities approach for localized adult extremity soft-tissue sarcoma",
abstract = "Extremity soft-tissue sarcomasare a heterogeneous group of rare neoplasms, characterized by a broad spectrum of biological aggressiveness and a uniform tendency for local failure if not adequately treated. Surgery is the mainstay of therapy, and the availability of multidisciplinary surgical skills allows adequate margins with acceptable morbidity to be obtained. Local therapies, such as radiation therapy or isolated limb perfusion, alone or in combination with systemic agents, may help to further improve local control, especially in difficult presentations. The possible impact of systemic treatment on survival is still a matter of debate, and the agents used so far have not provided a major breakthrough, even in selected populations at high dsk of disease spread. Nevertheless, soft-tissue sarcomas are no longer considered a unique disease. More than 50 different histotypes can now be well recognized, with distinct biological and molecular characteristics, which lead to different clinical behavior and a potentially different sensitivity to targeted agents. Therefore, it is more essential than ever for treatment of these patients to be delivered in referral centers, where a dedicated multidisciplinary team is able to administer histology and clinically driven approaches. The employment of combined modalities will be able to maximize the chance of local cure even in difficult presentations, and possibly improve survival, especially in high-risk disease.",
keywords = "Chemotherapy, Combined modalities, Isolated limb perfusion, Limb, Prognosis, Radiotherapy, Sarcoma, Surgery, Targeted therapy",
author = "Alessandro Gronchi and Patrizia Olmi and Casali, {Paolo G.}",
year = "2007",
month = "8",
doi = "10.1586/14737140.7.8.1135",
language = "English",
volume = "7",
pages = "1135--1144",
journal = "Expert Review of Molecular Diagnostics",
issn = "1473-7159",
publisher = "Expert Reviews Ltd.",
number = "8",

}

TY - JOUR

T1 - Combined modalities approach for localized adult extremity soft-tissue sarcoma

AU - Gronchi, Alessandro

AU - Olmi, Patrizia

AU - Casali, Paolo G.

PY - 2007/8

Y1 - 2007/8

N2 - Extremity soft-tissue sarcomasare a heterogeneous group of rare neoplasms, characterized by a broad spectrum of biological aggressiveness and a uniform tendency for local failure if not adequately treated. Surgery is the mainstay of therapy, and the availability of multidisciplinary surgical skills allows adequate margins with acceptable morbidity to be obtained. Local therapies, such as radiation therapy or isolated limb perfusion, alone or in combination with systemic agents, may help to further improve local control, especially in difficult presentations. The possible impact of systemic treatment on survival is still a matter of debate, and the agents used so far have not provided a major breakthrough, even in selected populations at high dsk of disease spread. Nevertheless, soft-tissue sarcomas are no longer considered a unique disease. More than 50 different histotypes can now be well recognized, with distinct biological and molecular characteristics, which lead to different clinical behavior and a potentially different sensitivity to targeted agents. Therefore, it is more essential than ever for treatment of these patients to be delivered in referral centers, where a dedicated multidisciplinary team is able to administer histology and clinically driven approaches. The employment of combined modalities will be able to maximize the chance of local cure even in difficult presentations, and possibly improve survival, especially in high-risk disease.

AB - Extremity soft-tissue sarcomasare a heterogeneous group of rare neoplasms, characterized by a broad spectrum of biological aggressiveness and a uniform tendency for local failure if not adequately treated. Surgery is the mainstay of therapy, and the availability of multidisciplinary surgical skills allows adequate margins with acceptable morbidity to be obtained. Local therapies, such as radiation therapy or isolated limb perfusion, alone or in combination with systemic agents, may help to further improve local control, especially in difficult presentations. The possible impact of systemic treatment on survival is still a matter of debate, and the agents used so far have not provided a major breakthrough, even in selected populations at high dsk of disease spread. Nevertheless, soft-tissue sarcomas are no longer considered a unique disease. More than 50 different histotypes can now be well recognized, with distinct biological and molecular characteristics, which lead to different clinical behavior and a potentially different sensitivity to targeted agents. Therefore, it is more essential than ever for treatment of these patients to be delivered in referral centers, where a dedicated multidisciplinary team is able to administer histology and clinically driven approaches. The employment of combined modalities will be able to maximize the chance of local cure even in difficult presentations, and possibly improve survival, especially in high-risk disease.

KW - Chemotherapy

KW - Combined modalities

KW - Isolated limb perfusion

KW - Limb

KW - Prognosis

KW - Radiotherapy

KW - Sarcoma

KW - Surgery

KW - Targeted therapy

UR - http://www.scopus.com/inward/record.url?scp=34548413977&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548413977&partnerID=8YFLogxK

U2 - 10.1586/14737140.7.8.1135

DO - 10.1586/14737140.7.8.1135

M3 - Article

VL - 7

SP - 1135

EP - 1144

JO - Expert Review of Molecular Diagnostics

JF - Expert Review of Molecular Diagnostics

SN - 1473-7159

IS - 8

ER -